Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.22B | 2.59B | 2.01B | 2.31B | 2.73B | 2.36B |
Gross Profit | 507.46M | 609.75M | 476.98M | 548.05M | 647.27M | 633.01M |
EBITDA | 156.34M | 249.74M | 183.35M | 221.43M | 296.00M | 323.92M |
Net Income | 115.51M | 154.39M | 100.85M | 130.29M | 213.31M | 203.02M |
Balance Sheet | ||||||
Total Assets | 4.34B | 4.36B | 4.14B | 4.15B | 4.43B | 4.38B |
Cash, Cash Equivalents and Short-Term Investments | 1.01B | 528.18M | 825.78M | 669.15M | 696.31M | 1.20B |
Total Debt | 15.31M | 17.54M | 17.34M | 19.93M | 27.72M | 70.73M |
Total Liabilities | 1.23B | 1.27B | 1.07B | 1.08B | 1.20B | 1.37B |
Stockholders Equity | 3.09B | 3.08B | 3.06B | 3.05B | 3.21B | 3.00B |
Cash Flow | ||||||
Free Cash Flow | 154.28M | -170.49M | 265.09M | 85.94M | -390.33M | 200.74M |
Operating Cash Flow | 217.07M | -98.87M | 323.04M | 149.87M | -259.76M | 241.78M |
Investing Cash Flow | -112.12M | -116.41M | -64.55M | -14.94M | -128.76M | -40.33M |
Financing Cash Flow | -54.17M | -59.10M | -68.11M | -123.48M | -151.90M | -94.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | 35.50B | 10.05 | 14.78% | 3.34% | 16.15% | 17.32% | |
78 Outperform | 24.82B | 10.38 | 10.89% | 2.12% | 34.78% | 98.79% | |
74 Outperform | $1.19B | 7.68 | 5.04% | 6.45% | 29.12% | 53.10% | |
68 Neutral | 6.96B | 11.20 | 0.00% | 2.01% | 11.18% | 46.57% | |
65 Neutral | 6.44B | 18.39 | 17.59% | 1.58% | -0.21% | -27.21% | |
56 Neutral | 6.55B | -542.71 | 0.00% | ― | 3.13% | 80.99% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Chen Hsong Holdings Limited has announced its annual general meeting scheduled for August 28, 2025, where key agenda items include the approval of financial statements, the re-election of directors, and the reappointment of Ernst & Young as auditors. Additionally, the company seeks shareholder approval for the repurchase of shares and the issuance of additional shares, indicating a strategic focus on optimizing capital structure and enhancing shareholder value.
Chen Hsong Holdings Limited has announced a Special General Meeting to discuss and potentially approve two new schemes: the 2025 Share Option Scheme and the 2025 Share Award Scheme. These schemes aim to incentivize and reward eligible participants by allowing them to acquire shares, with the total shares issued under these schemes not exceeding 10% of the company’s current shares. The approval and implementation of these schemes are subject to the necessary permissions from the Hong Kong Stock Exchange, and they signify a strategic move to enhance employee engagement and align their interests with the company’s growth objectives.
Chen Hsong Holdings Limited reported a significant financial performance for the year ended March 31, 2025, with a 29% increase in revenue and a 53% rise in profit attributable to equity holders compared to the previous year. This robust growth in financial metrics underscores the company’s strong operational capabilities and positions it favorably within the industry, potentially benefiting stakeholders through increased dividends and stable asset management.
Chen Hsong Holdings Limited has announced a final ordinary dividend of HKD 0.08 per share for the financial year ending 31 March 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders, with the payment date set for 22 September 2025.
Chen Hsong Holdings Limited, a company listed on the Hong Kong Stock Exchange, announced the retirement of Mr. Michael Tze Hau Lee as an Independent Non-executive Director, effective from the conclusion of the upcoming annual general meeting on August 28, 2025. Mr. Lee will also step down from his roles in various board committees, with Mr. Harry Chi Hui set to take over as Chairman of the Corporate Governance Committee. The company expressed gratitude for Mr. Lee’s contributions and welcomed Mr. Hui to his new role.
Chen Hsong Holdings Limited has updated the terms of reference for its Nomination Committee, emphasizing the inclusion of diverse and independent perspectives. The committee, which plays a crucial role in board appointments, will now require a minimum of three members, with a majority being independent non-executive directors, and mandates gender diversity among its members.
Chen Hsong Holdings Limited has announced that its board of directors will meet on June 20, 2025, to approve the company’s annual results for the year ending March 31, 2025. The meeting will also consider the recommendation for a final dividend or other distribution, which could impact shareholder returns and reflect the company’s financial health.